NeuroImage ClinicalNeurosciencePeer-reviewed journal article
White Matter Hyperintensity Distribution Differences in Aging and Neurodegenerative Disease Cohorts
Mahsa DadariD, Sawsan Mahmoud, Maryna ZhernovaiaiD, Richard M. CamicioliiD, Josefina MaranzanoiD, Simon DuchesneiD, For the CCNA Group
Abstract
IntroductionWhite matter hyperintensities (WMHs) are common magnetic resonance imaging (MRI) findings in the aging population in general, as well as in patients with neurodegenerative diseases. They are known to exacerbate the cognitive deficits and worsen the clinical outcomes in the patients. However, it is not well-understood whether there are disease-specific differences in prevalence and distribution of WMHs in different neurodegenerative disorders. MethodsData included 976 participants with cross-sectional T1-weighted and fluid attenuated inversion recovery (FLAIR) MRIs from the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) cohort of the Canadian Consortium on Neurodegeneration in Aging (CCNA) with eleven distinct diagnostic groups: cognitively intact elderly (CIE), subjective cognitive impairment (SCI), mild cognitive impairment (MCI), vascular MCI (V-MCI), Alzheimers dementia (AD), vascular AD (V-AD), frontotemporal dementia (FTD), Lewy body dementia (LBD), cognitively intact elderly with Parkinsons disease (PD-CIE), cognitively impaired Parkinsons disease (PD-CI), and mixed dementias. WMHs were segmented using a previously validated automated technique. WMH volumes in each lobe and hemisphere were compared against matched CIE individuals, as well as each other, and between men and women. ResultsAll cognitively impaired diagnostic groups had significantly greater overall WMH volumes than the CIE group. Vascular groups (i.e. V-MCI, V-AD, and mixed dementia) had significantly greater WMH volumes than all other groups, except for FTD, which also had significantly greater WMH volumes than all non-vascular groups. Women tended to have lower WMH burden than men in most groups and regions, controlling for age. The left frontal lobe tended to have a lower WMH burden than the right in all groups. In contrast, the right occipital lobe tended to have greater WMH loads than the left. ConclusionsThere were distinct differences in WMH prevalence and distribution across diagnostic groups, sexes, and in terms of asymmetry. WMH burden was significantly greater in all neurodegenerative dementia groups, likely encompassing areas exclusively impacted by neurodegeneration as well as areas related to cerebrovascular disease pathology.
- Citations
- 59
- FWCI
- 6.18
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- White Matter Hyperintensities, Grey Matter Atrophy, and Cognitive Decline in Neurodegenerative Diseases
Mahsa Dadar, Ana Laura Manera, D. Louis Collins·bioRxiv·Apr 6, 2021
- Periventricular and Deep White Matter Hyperintensity Thresholds in Aging: Exponential Progression, Cognitive Decline, and Neuroanatomic Atrophy
Niraj Kumar Gupta, Neha Yadav, Vivek Tiwari·bioRxiv·Sep 3, 2024
- Topographic reference modelling of white matter hyperintensities across the adult lifespan
Mohamad J. Alshikho, Jeffrey D. Pyne, … Adam M. Brickman·bioRxiv·Nov 3, 2026
- Spatial Gradient of Microstructural Changes in Normal-Appearing White Matter in Tracts Affected by White Matter Hyperintensities in Older Age
Susana Muñoz Maniega, Rozanna Meijboom, … Joanna Marguerite Wardlaw·Frontiers in NeurologyPeer-reviewed·Jul 25, 2019
- Magnitude and Kinetics of a set of Neuroanatomic Volume and Thickness together with White Matter Hyperintensity is definitive of Cognitive Status and Brain Age
Neha Yadav, Niraj Kumar Gupta, … Vivek Tiwari·Translational PsychiatryPeer-reviewed·Sep 27, 2024
- Spatial Patterns of White Matter Hyperintensities and Cognitive Function in Older Adults: A Community-Based Study
Xingyu Chen, Kei Nishimaki, … Kenichi Oishi·bioRxiv·Oct 20, 2026